Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Supporters often stress the potential for meaningful therapeutic gains, particularly in ailments where conventional medications have proven inadequate. However, crucially important to evaluate the substantial financial investment associated with CPI stem